To elucidate the regulatory mechanism of CD276 in bladder cancer, GSEA and pathway visualization were conducted based on the differentially expressed genes between BLCA tissues and control samples (Figure 5A). The gene discussed is CD276; the disease is bladder transitional cell carcinoma.